 |
avelumab (Recombinant human monoclonal IgG1 antibody against programmed death ligand-1) |
|---|---|
| Trade Name | Bavencio |
| Orphan Indication | Merkel cell cancer |
| USA Market Approval | USA |
| USA Designation Date | 2015-09-21 00:00:00 |
| Sponsor | EMD Serono Research and Development Institute, Inc.;45A Middlesex Turnpike; |
Related Access Program